Clinical trial
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
NCT01735214 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments
- Lead sponsor
- Allergan
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 7, 2013
- Completion date
- April 10, 2014
- Enrollment
- 358 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.